Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Studies on Artificial Intelligence for Cancer Pathology Evaluation

NCT07203885 is registered in ClinicalTrials.gov with Harvard Medical School (HMS and HSDM) as lead sponsor.

NCT NCT07203885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07203885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Studies on Artificial Intelligence for Cancer Pathology Evaluation
Lead sponsor
Harvard Medical School (HMS and HSDM)
Phase
Not applicable
Overall status
Completed
Start date
September 9, 2025
Completion date
October 10, 2025
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukaemia (aml), acute promyelocytic leukemia (apl)